BackIntelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War) Overview
Intelligent Medicine Acquisition Corp - Units (1 Ord Share Class A & 1/2 War)

Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War) Return on Equity

Valuation check: IQMDU's ROE is 2157193.89%, above the sector sector average of -5.87%.

Get informed when a big investor buys or sells

+ Follow

ROE

2157193.89%

Return on Equity

2157193.89%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

Average ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War) (IQMDU) FAQ

The latest ROE for IQMDU is 2157193.89%. That is above the sector sector average of -5.87%. Investors often review this figure alongside Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War)'s historical trend and sector peers before judging valuation or financial health.

Against its sector companies, IQMDU currently prints 2157193.89% for ROE, while the sector average sits near -5.87%. That is roughly 36758814.9% above the sector mean. Large gaps often invite a closer look at Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War)'s growth, margins, and balance sheet.

Return on Equity shows how effectively Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War) converts resources into returns. At 2157193.89%, IQMDU may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting IQMDU's ROE (2157193.89%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.